{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:42:39Z","timestamp":1788385359865,"version":"build-2803163510"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10787-024-01524-w","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T10:01:56Z","timestamp":1721296916000},"page":"3271-3293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u2018Comprehensive review of emerging drug targets in traumatic brain injury (TBI): challenges and future scope"],"prefix":"10.1007","volume":"32","author":[{"given":"Rittu","family":"Banderwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukant","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-6197","authenticated-orcid":false,"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"issue":"2","key":"1524_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/2045-9912.311498","volume":"11","author":"F Ahmadi","year":"2021","unstructured":"Ahmadi F, Khalatbary AR (2021) A review on the neuroprotective effects of hyperbaric oxygen therapy. Medical Gas Res 11(2):72. https:\/\/doi.org\/10.4103\/2045-9912.311498","journal-title":"Medical Gas Res"},{"key":"1524_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s13311-020-00840-7","volume":"17","author":"Y Akamatsu","year":"2020","unstructured":"Akamatsu Y, Hanafy KA (2020) Cell death and recovery in traumatic brain injury. Neurotherapeutics 17:446\u2013456. https:\/\/doi.org\/10.1007\/s13311-020-00840-7","journal-title":"Neurotherapeutics"},{"issue":"10","key":"1524_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/antiox8100430","volume":"8","author":"SH Aladaileh","year":"2019","unstructured":"Aladaileh SH, Hussein OE, Abukhalil MH, Saghir SA et al (2019) Formononetin upregulates Nrf2\/HO-1 signaling and prevents oxidative stress, inflammation, and kidney injury in methotrexate-induced rats. Antioxidants 8(10):430. https:\/\/doi.org\/10.3390\/antiox8100430","journal-title":"Antioxidants"},{"key":"1524_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-02005-x","volume":"17","author":"A Alam","year":"2020","unstructured":"Alam A, Thelin EP, Tajsic T et al (2020) Cellular infiltration in traumatic brain injury. J Neuroinflammation 17:1\u20137. https:\/\/doi.org\/10.1186\/s12974-020-02005-x","journal-title":"J Neuroinflammation"},{"issue":"9","key":"1524_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/pharmaceutics11090473","volume":"11","author":"B Alam Bony","year":"2019","unstructured":"Alam Bony B, Kievit FM (2019) A role for nanoparticles in treating traumatic brain injury. Pharmaceutics 11(9):473. https:\/\/doi.org\/10.3390\/pharmaceutics11090473","journal-title":"Pharmaceutics"},{"issue":"10","key":"1524_CR6","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1523\/JNEUROSCI.2197-17.2018","volume":"38","author":"A Alawieh","year":"2018","unstructured":"Alawieh A, Langley EF, Weber S et al (2018) Identifying the role of complement in triggering neuroinflammation after traumatic brain injury. J Neurosci 38(10):2519\u20132532. https:\/\/doi.org\/10.1523\/JNEUROSCI.2197-17.2018","journal-title":"J Neurosci"},{"issue":"14","key":"1524_CR7","doi-asserted-by":"publisher","first-page":"R790","DOI":"10.1016\/j.cub.2020.05.051","volume":"30","author":"A Alquraini","year":"2020","unstructured":"Alquraini A, El Khoury J (2020) Scavenger receptors. Curr Biol 30(14):R790\u2013R795. https:\/\/doi.org\/10.1016\/j.cub.2020.05.051","journal-title":"Curr Biol"},{"key":"1524_CR8","doi-asserted-by":"publisher","first-page":"690407","DOI":"10.3389\/fphar.2021.690407","volume":"12","author":"S Baby","year":"2021","unstructured":"Baby S, Gruber R, Discala J, Puskovic V, Jose N, Cheng F, Jenkins M, Seckler J, Lewis S (2021) Systemic administration of tempol attenuates the cardiorespiratory depressant effects of fentanyl. Front Pharmacol 12:690407. https:\/\/doi.org\/10.3389\/fphar.2021.690407","journal-title":"Front Pharmacol"},{"issue":"16","key":"1524_CR9","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.7150\/ijms.46834","volume":"18","author":"W Bao","year":"2021","unstructured":"Bao W, Lin Y, Chen Z (2021) The peripheral immune system and traumatic brain injury: insight into the role of T-helper cells. Int J Med Sci 18(16):3644\u20133651. https:\/\/doi.org\/10.7150\/ijms.46834","journal-title":"Int J Med Sci"},{"issue":"5","key":"1524_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10715760600617843","volume":"40","author":"HN Bhagavan","year":"2006","unstructured":"Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40(5):445\u2013453. https:\/\/doi.org\/10.1080\/10715760600617843","journal-title":"Free Radic Res"},{"issue":"3","key":"1524_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/00003088-199835030-00004","volume":"35","author":"BA Boucher","year":"1998","unstructured":"Boucher BA, Hanes SD (1998) Pharmacokinetic alterations after severe head injury. Clin Relevance Clin Pharmacokinet 35(3):209\u2013221. https:\/\/doi.org\/10.2165\/00003088-199835030-00004","journal-title":"Clin Relevance Clin Pharmacokinet"},{"issue":"3","key":"1524_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1034\/j.1399-6576.2001.045003390.x","volume":"45","author":"R Bouw","year":"2001","unstructured":"Bouw R, Ederoth P, Lundberg J et al (2001) Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis. Acta Anaesthesiol Scand 45(3):390\u2013392. https:\/\/doi.org\/10.1034\/j.1399-6576.2001.045003390.x","journal-title":"Acta Anaesthesiol Scand"},{"issue":"7","key":"1524_CR13","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1167\/iovs.18-24431","volume":"59","author":"CT Brian","year":"2018","unstructured":"Brian CT, Dvoriantchikova G, Tao W et al (2018) Tumor necrosis factor inhibition in the acute management of traumatic optic neuropathy. Invest Ophthalmol vis Sci 59(7):2905\u20132912. https:\/\/doi.org\/10.1167\/iovs.18-24431","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"1","key":"1524_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/brainsci10010020","volume":"10","author":"C Bureta","year":"2019","unstructured":"Bureta C, Setoguchi T, Saitoh Y et al (2019) TGF-\u03b2 promotes the proliferation of microglia in vitro. Brain Sci 10(1):20. https:\/\/doi.org\/10.3390\/brainsci10010020","journal-title":"Brain Sci"},{"issue":"10","key":"1524_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT (2020) Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci 23(10):1183\u20131193. https:\/\/doi.org\/10.1038\/s41593-020-0687-6","journal-title":"Nat Neurosci"},{"issue":"2","key":"1524_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","volume":"104","author":"A Capizzi","year":"2020","unstructured":"Capizzi A, Woo J, Verduzco-Gutierrez M (2020) Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management. Med Clin North Am 104(2):213\u2013238. https:\/\/doi.org\/10.1016\/j.mcna.2019.11.001","journal-title":"Med Clin North Am"},{"issue":"8","key":"1524_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/sctm.19-0444","volume":"9","author":"HW Caplan","year":"2020","unstructured":"Caplan HW, Prabhakara KS, Kumar A et al (2020) Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury. Stem Cells Transl Med 9(8):903\u2013916. https:\/\/doi.org\/10.1002\/sctm.19-0444","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"1524_CR18","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.3390\/molecules15118478","volume":"15","author":"Y Chen","year":"2010","unstructured":"Chen Y, Jia X, Chen J, Wang J, Hu M (2010) The pharmacokinetics of raloxifene and its interaction with apigenin in rat. Molecules 15(11):8478\u20138487. https:\/\/doi.org\/10.3390\/molecules15118478","journal-title":"Molecules"},{"issue":"2","key":"1524_CR19","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1111\/ejn.14374","volume":"50","author":"J Chen","year":"2019","unstructured":"Chen J, Chen W, Han K et al (2019) Effect of oxidative stress in rostral ventrolateral medulla on sympathetic hyperactivity after traumatic brain injury. Eur J Neurosci 50(2):1972\u20131980. https:\/\/doi.org\/10.1111\/ejn.14374","journal-title":"Eur J Neurosci"},{"issue":"2","key":"1524_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.31083\/j.jin.2019.02.110","volume":"18","author":"X Cheng","year":"2019","unstructured":"Cheng X, Wang J, Sun X et al (2019) Morphological and functional alterations of astrocytes responding to traumatic brain injury. J Integr Neurosci 18(2):203\u2013215. https:\/\/doi.org\/10.31083\/j.jin.2019.02.110","journal-title":"J Integr Neurosci"},{"key":"1524_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2016.11.001","volume":"63","author":"V Chhor","year":"2017","unstructured":"Chhor V, Moretti R, Le Charpentier T et al (2017) Role of microglia in a mouse model of paediatric traumatic brain injury. Brain Behav Immun 63:197\u2013209. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.001","journal-title":"Brain Behav Immun"},{"key":"1524_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbr.2017.08.035","volume":"336","author":"LE Collins-Praino","year":"2018","unstructured":"Collins-Praino LE, Arulsamy A, Katharesan V et al (2018) The effect of an acute systemic inflammatory insult on the chronic effects of a single mild traumatic brain injury. Behav Brain Res 336:22\u201331. https:\/\/doi.org\/10.1016\/j.bbr.2017.08.035","journal-title":"Behav Brain Res"},{"issue":"21","key":"1524_CR23","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2018.17075","volume":"320","author":"DJ Cooper","year":"2018","unstructured":"Cooper DJ, Nichol AD, Bailey M et al (2018) Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA 320(21):2211\u20132220. https:\/\/doi.org\/10.1001\/jama.2018.17075","journal-title":"JAMA"},{"key":"1524_CR24","doi-asserted-by":"crossref","unstructured":"Daglas M, Medcalf RL, Sashindranath M (2022) The adaptive immune system in traumatic brain injury: A focus on T and B lymphocytes. In Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury. Academic Press 161\u2013174.","DOI":"10.1016\/B978-0-12-823036-7.00044-X"},{"key":"1524_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12031-019-01475-w","volume":"70","author":"F Dehghanian","year":"2020","unstructured":"Dehghanian F, Soltani Z, Khaksari M (2020) Can mesenchymal stem cells act multipotential in traumatic brain injury? J Mol Neurosci 70:677\u2013688. https:\/\/doi.org\/10.1007\/s12031-019-01475-w","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1524_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10JNS17352","volume":"130","author":"MC Dewan","year":"2018","unstructured":"Dewan MC, Rattani A, Gupta S et al (2018) Estimating the global incidence of traumatic brain injury. J Neurosurg 130(4):1080\u20131097. https:\/\/doi.org\/10.3171\/2017.10JNS17352","journal-title":"J Neurosurg"},{"issue":"3","key":"1524_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/antiox9030260","volume":"9","author":"V Di Pietro","year":"2020","unstructured":"Di Pietro V, Yakoub KM, Caruso G et al (2020) Antioxidant therapies in traumatic brain injury. Antioxidants 9(3):260. https:\/\/doi.org\/10.3390\/antiox9030260","journal-title":"Antioxidants"},{"key":"1524_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3389\/fnins.2019.01178","volume":"13","author":"V Dinet","year":"2019","unstructured":"Dinet V, Petry KG, Badaut J (2019) Brain\u2013immune interactions and neuroinflammation after traumatic brain injury. Front Neurosci 13:1178. https:\/\/doi.org\/10.3389\/fnins.2019.01178","journal-title":"Front Neurosci"},{"issue":"13","key":"1524_CR29","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acschemneuro.2c00196","volume":"13","author":"Z Doganyigit","year":"2022","unstructured":"Doganyigit Z, Erbakan K, Akyuz E et al (2022) The role of neuroinflammatory mediators in the pathogenesis of traumatic brain injury: a narrative review. ACS Chem Neurosci 13(13):1835\u20131848. https:\/\/doi.org\/10.1021\/acschemneuro.2c00196","journal-title":"ACS Chem Neurosci"},{"key":"1524_CR30","doi-asserted-by":"publisher","first-page":"620948","DOI":"10.3389\/fneur.2021.620948","volume":"12","author":"R Dong","year":"2021","unstructured":"Dong R, Huang R, Wang J et al (2021) Effects of microglial activation and polarization on brain injury after stroke. Front Neurol 12:620948. https:\/\/doi.org\/10.3389\/fneur.2021.620948","journal-title":"Front Neurol"},{"issue":"02","key":"1524_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-0040-1709363","volume":"11","author":"J Dunne","year":"2020","unstructured":"Dunne J, Qui\u00f1ones-Ossa GA, Still EG et al (2020) The epidemiology of traumatic brain injury due to traffic accidents in Latin America: a narrative review. J Neurosci Rural Prac 11(02):287\u2013290. https:\/\/doi.org\/10.1055\/s-0040-1709363","journal-title":"J Neurosci Rural Prac"},{"key":"1524_CR32","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(05)66552-X","volume":"365","author":"P Edwards","year":"2005","unstructured":"Edwards P, Arango M, Balica L et al (2005) Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 365:1957\u20131959. https:\/\/doi.org\/10.1016\/S0140-6736(05)66552-X","journal-title":"Lancet"},{"issue":"2","key":"1524_CR33","first-page":"84","volume":"7","author":"M Eghbali","year":"2020","unstructured":"Eghbali M, Khankeh H, Ebadi A (2020) The importance of early rehabilitation in traumatic brain injury. Nurs Pract Today 7(2):84\u201386","journal-title":"Nurs Pract Today"},{"key":"1524_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000003858","author":"M El Baassiri","year":"2023","unstructured":"El Baassiri M, Chun Y, Rahal S et al (2023) Infiltrating anti-inflammatory monocytes modulate microglial activation through TLR4-IFN dependent pathways following traumatic brain injury. J Trauma Acute Care Surg. https:\/\/doi.org\/10.1097\/TA.0000000000003858","journal-title":"J Trauma Acute Care Surg"},{"key":"1524_CR35","doi-asserted-by":"publisher","first-page":"134294","DOI":"10.1016\/j.neulet.2019.134294","volume":"707","author":"GA Elder","year":"2019","unstructured":"Elder GA, Ehrlich ME, Gandy S (2019) Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans. Neurosci Lett 707:134294. https:\/\/doi.org\/10.1016\/j.neulet.2019.134294","journal-title":"Neurosci Lett"},{"issue":"1","key":"1524_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01994-z","volume":"17","author":"E Eyolfson","year":"2020","unstructured":"Eyolfson E, Khan A, Mychasiuk R et al (2020) Microglia dynamics in adolescent traumatic brain injury. J Neuroinflammation 17(1):1\u20139. https:\/\/doi.org\/10.1186\/s12974-020-01994-z","journal-title":"J Neuroinflammation"},{"key":"1524_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainres.2018.05.044","volume":"1696","author":"G Feng","year":"2018","unstructured":"Feng G, Feng J, Zhang S et al (2018) Altered levels of \u03b1-melanocyte stimulating hormone in cerebrospinal fluid and plasma of patients with traumatic brain injury. Brain Res 1696:22\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2018.05.044","journal-title":"Brain Res"},{"issue":"7598","key":"1524_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud L, Trav\u00e9s PG, Tufail Y et al (2016) TAM receptors regulate multiple features of microglial physiology. Nature 532(7598):240\u2013244. https:\/\/doi.org\/10.1038\/nature17630","journal-title":"Nature"},{"key":"1524_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jnc.13217","volume":"136","author":"LC Freeman","year":"2016","unstructured":"Freeman LC, Ting JP (2016) The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem 136:29\u201338. https:\/\/doi.org\/10.1111\/jnc.13217","journal-title":"J Neurochem"},{"issue":"7","key":"1524_CR40","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0963689717714102","volume":"26","author":"M Galgano","year":"2017","unstructured":"Galgano M, Toshkezi G, Qiu X et al (2017) Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant 26(7):1118\u20131130. https:\/\/doi.org\/10.1177\/0963689717714102","journal-title":"Cell Transplant"},{"issue":"1","key":"1524_CR41","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.bbrc.2018.02.102","volume":"497","author":"T Gao","year":"2018","unstructured":"Gao T, Chen Z, Chen H et al (2018) Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia\/macrophage polarization. Biochem Biophys Res Commun 497(1):430\u2013436. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.102","journal-title":"Biochem Biophys Res Commun"},{"key":"1524_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113712","volume":"341","author":"P Gao","year":"2021","unstructured":"Gao P, Tang S, Chen H et al (2021) Preconditioning increases brain resistance against acute brain injury via neuroinflammation modulation. Exp Neurol 341:113712. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113712","journal-title":"Exp Neurol"},{"key":"1524_CR43","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pnpbp.2019.02.004","volume":"92","author":"RR Gerbatin","year":"2019","unstructured":"Gerbatin RR, Silva LF, Hoffmann MS et al (2019) Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in rats. Prog Neuro-Psychopharmacol Biol Psych 92:328\u2013338. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.02.004","journal-title":"Prog Neuro-Psychopharmacol Biol Psych"},{"issue":"15","key":"1524_CR45","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.3390\/ijms21155271","volume":"21","author":"R Guennoun","year":"2020","unstructured":"Guennoun R (2020) Progesterone in the brain: hormone, neurosteroid and neuroprotectant. Int J Mol Sci 21(15):5271. https:\/\/doi.org\/10.3390\/ijms21155271","journal-title":"Int J Mol Sci"},{"key":"1524_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuropharm.2018.08.005","volume":"145","author":"ED Hall","year":"2019","unstructured":"Hall ED, Wang JA, Miller DM et al (2019) Newer pharmacological approaches for antioxidant neuroprotection in traumatic brain injury. Neuropharmacology 145:247\u2013258. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.08.005","journal-title":"Neuropharmacology"},{"issue":"1","key":"1524_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1066-z","volume":"15","author":"A Hammad","year":"2018","unstructured":"Hammad A, Westacott L, Zaben M (2018) The role of the complement system in traumatic brain injury: a review. J Neuroinflammation 15(1):1\u20135. https:\/\/doi.org\/10.1186\/s12974-018-1066-z","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1524_CR48","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","volume":"71","author":"NG Harps\u00f8e","year":"2015","unstructured":"Harps\u00f8e NG, Andersen LP, G\u00f6genur I, Rosenberg J (2015) Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol 71(8):901\u2013909. https:\/\/doi.org\/10.1007\/s00228-015-1873-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1524_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MAJ.0000000000000506","volume":"350","author":"JB Hiebert","year":"2015","unstructured":"Hiebert JB, Shen Q, Thimmesch AR (2015) Traumatic brain injury and mitochondrial dysfunction. Am J Med Sci 350(2):132\u2013138. https:\/\/doi.org\/10.1097\/MAJ.0000000000000506","journal-title":"Am J Med Sci"},{"issue":"1","key":"1524_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0301-2115(98)00278-4","volume":"85","author":"D Hochner-Celnikier","year":"1999","unstructured":"Hochner-Celnikier D (1999) Pharmacokinetics of raloxifene and its clinical application. Eur J Obstet Gynecol Reprod Biol 85(1):23\u201329. https:\/\/doi.org\/10.1016\/s0301-2115(98)00278-4","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1524_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20(2):123\u2013134. https:\/\/doi.org\/10.2165\/00003088-199120020-00004","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"1524_CR52","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. Cell Mol Immunol 18(9):2114\u20132127. https:\/\/doi.org\/10.1038\/s41423-021-00740-6","journal-title":"Cell Mol Immunol"},{"key":"1524_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuroscience.2016.01.022","volume":"319","author":"BR Huber","year":"2016","unstructured":"Huber BR, Meabon JS, Hoffer ZS et al (2016) Blast exposure causes dynamic microglial\/macrophage responses and microdomains of brain microvessel dysfunction. Neuroscience 319:206\u2013220. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.022","journal-title":"Neuroscience"},{"issue":"5","key":"1524_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.23736\/S0390-5616.18.04532-0","volume":"62","author":"C Iaccarino","year":"2018","unstructured":"Iaccarino C, Carretta A, Nicolosi F et al (2018) Epidemiology of severe traumatic brain injury. J Neurosurg Sci 62(5):535\u2013541. https:\/\/doi.org\/10.23736\/S0390-5616.18.04532-0","journal-title":"J Neurosurg Sci"},{"issue":"17","key":"1524_CR55","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.3390\/ijms21176204","volume":"21","author":"N Irrera","year":"2020","unstructured":"Irrera N, Russo M, Pallio G et al (2020) The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. Int J Mol Sci 21(17):6204. https:\/\/doi.org\/10.3390\/ijms21176204","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1524_CR56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/1673-5374.286951","volume":"16","author":"S Ismael","year":"2021","unstructured":"Ismael S, Ahmed HA, Adris T et al (2021) The NLRP3 inflammasome: a potential therapeutic target for traumatic brain injury. Neural Regen Res 16(1):49. https:\/\/doi.org\/10.4103\/1673-5374.286951","journal-title":"Neural Regen Res"},{"issue":"10","key":"1524_CR57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/antiox9100943","volume":"9","author":"H Ismail","year":"2020","unstructured":"Ismail H, Shakkour Z, Tabet M et al (2020) Traumatic brain injury: oxidative stress and novel anti-oxidants such as mitoquinone and edaravone. Antioxidants 9(10):943. https:\/\/doi.org\/10.3390\/antiox9100943","journal-title":"Antioxidants"},{"issue":"6","key":"1524_CR58","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","volume":"95","author":"YN Jassam","year":"2017","unstructured":"Jassam YN, Izzy S, Whalen M, McGavern DB, El Khoury J et al (2017) Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron 95(6):1246\u20131265. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.010","journal-title":"Neuron"},{"key":"1524_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2022.08.014","author":"NH Johnson","year":"2022","unstructured":"Johnson NH, de Rivero Vaccari JP, Bramlett HM et al (2022) Inflammasome activation in traumatic brain injury and Alzheimer\u2019s disease. Transl Res. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.014","journal-title":"Transl Res"},{"issue":"12","key":"1524_CR60","doi-asserted-by":"publisher","first-page":"16786","DOI":"10.1007\/s11356-021-18391-5","volume":"29","author":"S Kalra","year":"2022","unstructured":"Kalra S, Banderwal R, Arora K et al (2022) An update on pathophysiology and treatment of sports-mediated brain injury. Environ Sci Pollut Res 29(12):16786\u201316798. https:\/\/doi.org\/10.1007\/s11356-021-18391-5","journal-title":"Environ Sci Pollut Res"},{"issue":"3","key":"1524_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","volume":"68","author":"IM Kapetanovic","year":"2011","unstructured":"Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68(3):593\u2013601. https:\/\/doi.org\/10.1007\/s00280-010-1525-4","journal-title":"Cancer Chemother Pharmacol"},{"issue":"18","key":"1524_CR62","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.0000000000011850","volume":"96","author":"DI Katz","year":"2021","unstructured":"Katz DI, Bernick C, Dodick DW et al (2021) National institute of neurological disorders and stroke consensus diagnostic criteria for traumatic encephalopathy syndrome. Neurology 96(18):848\u2013863. https:\/\/doi.org\/10.1212\/WNL.0000000000011850","journal-title":"Neurology"},{"issue":"8","key":"1524_CR63","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","volume":"16","author":"P Kaur","year":"2018","unstructured":"Kaur P, Sharma S (2018) Recent advances in pathophysiology of traumatic brain injury. Curr Neuropharmacol 16(8):1224\u20131238. https:\/\/doi.org\/10.2174\/1570159X15666170613083606","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"1524_CR64","doi-asserted-by":"publisher","first-page":"e0210128","DOI":"10.1371\/journal.pone.0210128","volume":"13","author":"N Kerr","year":"2018","unstructured":"Kerr N, Lee SW, Perez-Barcena J et al (2018) Inflammasome proteins as biomarkers of traumatic brain injury. PLoS ONE 13(12):e0210128. https:\/\/doi.org\/10.1371\/journal.pone.0210128","journal-title":"PLoS ONE"},{"issue":"4","key":"1524_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/biof.1516","volume":"45","author":"Z Keshavarzi","year":"2019","unstructured":"Keshavarzi Z, Shakeri F, Barreto GE et al (2019) Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited. BioFactors 45(4):517\u2013535. https:\/\/doi.org\/10.1002\/biof.1516","journal-title":"BioFactors"},{"issue":"1","key":"1524_CR66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/neu.2017.5588","volume":"36","author":"N Ketharanathan","year":"2019","unstructured":"Ketharanathan N, Yamamoto Y, Rohlwink UK et al (2019) Combining brain microdialysis and translational pharmacokinetic modeling to predict drug concentrations in pediatric severe traumatic brain injury: the next step toward evidence-based pharmacotherapy? J Neurotrauma 36(1):111\u2013117. https:\/\/doi.org\/10.1089\/neu.2017.5588","journal-title":"J Neurotrauma"},{"issue":"9","key":"1524_CR67","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2174\/1871527317666180627120501","volume":"17","author":"N Khatri","year":"2018","unstructured":"Khatri N, Thakur M, Pareek V et al (2018) Oxidative stress: major threat in traumatic brain injury. CNS Neurol Disord Drug Targets 17(9):689\u2013695. https:\/\/doi.org\/10.2174\/1871527317666180627120501","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1524_CR68","doi-asserted-by":"publisher","first-page":"113621","DOI":"10.1016\/j.biopha.2022.113621","volume":"154","author":"D Khayatan","year":"2022","unstructured":"Khayatan D, Razavi SM, Arab ZN et al (2022) Protective effects of curcumin against traumatic brain injury. Biomed Pharmacother 154:113621. https:\/\/doi.org\/10.1016\/j.biopha.2022.113621","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"1524_CR69","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/cells9092020","volume":"9","author":"JY Kim","year":"2020","unstructured":"Kim JY, Barua S, Huang MY et al (2020) Heat shock protein 70 (HSP70) induction: chaperonotherapy for neuroprotection after brain injury. Cells 9(9):2020. https:\/\/doi.org\/10.3390\/cells9092020","journal-title":"Cells"},{"issue":"5","key":"1524_CR70","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/cells10051098","volume":"10","author":"D Klaver","year":"2021","unstructured":"Klaver D, Thurnher M (2021) Control of macrophage inflammation by P2Y purinergic receptors. Cells 10(5):1098. https:\/\/doi.org\/10.3390\/cells10051098","journal-title":"Cells"},{"key":"1524_CR71","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","volume":"9","author":"ON Kokiko-Cochran","year":"2018","unstructured":"Kokiko-Cochran ON, Godbout JP (2018) The inflammatory continuum of traumatic brain injury and Alzheimer\u2019s disease. Front Immunol 9:672. https:\/\/doi.org\/10.3389\/fimmu.2018.00672","journal-title":"Front Immunol"},{"issue":"1","key":"1524_CR72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40779-021-00363-y","volume":"9","author":"LZ Kong","year":"2022","unstructured":"Kong LZ, Zhang RL, Hu SH et al (2022) Military traumatic brain injury: a challenge straddling neurology and psychiatry. Mil Med Res 9(1):2. https:\/\/doi.org\/10.1186\/s40779-021-00363-y","journal-title":"Mil Med Res"},{"issue":"12","key":"1524_CR73","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3390\/ijms19123753","volume":"19","author":"K Krukowski","year":"2018","unstructured":"Krukowski K, Chou A, Feng X et al (2018) Traumatic brain injury in aged mice induces chronic microglia activation, synapse loss, and complement-dependent memory deficits. Int J Mol Sci 19(12):3753. https:\/\/doi.org\/10.3390\/ijms19123753","journal-title":"Int J Mol Sci"},{"key":"1524_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2022.01.008","volume":"181","author":"T Kumagawa","year":"2022","unstructured":"Kumagawa T, Moro N, Maeda T et al (2022) Anti-inflammatory effect of P2Y1 receptor blocker MRS2179 in a rat model of traumatic brain injury. Brain Res Bull 181:46\u201354. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.01.008","journal-title":"Brain Res Bull"},{"issue":"3","key":"1524_CR75","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1124\/jpet.118.253955","volume":"368","author":"A Kumar","year":"2019","unstructured":"Kumar A, Henry RJ, Stoica BA et al (2019) Neutral sphingomyelinase inhibition alleviates LPS-induced microglia activation and neuroinflammation after experimental traumatic brain injury. J Pharmacol Exp Ther 368(3):338\u2013352. https:\/\/doi.org\/10.1124\/jpet.118.253955","journal-title":"J Pharmacol Exp Ther"},{"key":"1524_CR76","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.wneu.2019.07.039","volume":"131","author":"AA Ladak","year":"2019","unstructured":"Ladak AA, Enam SA, Ibrahim MT (2019) A review of the molecular mechanisms of traumatic brain injury. World Neurosurg 131:126\u2013132. https:\/\/doi.org\/10.1016\/j.wneu.2019.07.039","journal-title":"World Neurosurg"},{"issue":"3","key":"1524_CR77","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/jts.22480","volume":"33","author":"RT Lange","year":"2020","unstructured":"Lange RT, French LM, Lippa SM (2020) Posttraumatic stress disorder is a stronger predictor of long-term neurobehavioral outcomes than traumatic brain injury severity. J Trauma Stress 33(3):318\u2013329. https:\/\/doi.org\/10.1002\/jts.22480","journal-title":"J Trauma Stress"},{"issue":"4","key":"1524_CR78","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1211\/jpp.59.4.0004","volume":"59","author":"Y Li","year":"2007","unstructured":"Li Y, Fawcett JP, Zhang H, Tucker IG (2007a) Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers. J Pharm Pharmacol 59(4):503\u2013511. https:\/\/doi.org\/10.1211\/jpp.59.4.0004","journal-title":"J Pharm Pharmacol"},{"issue":"13","key":"1524_CR79","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/rcm.3048","volume":"21","author":"Y Li","year":"2007","unstructured":"Li Y, Zhang H, Fawcett JP, Tucker IG (2007b) Quantitation and metabolism of mitoquinone, a mitochondria-targeted antioxidant, in rat by liquid chromatography\/tandem mass spectrometry. Rapid Commun Mass Spectrom 21(13):1958\u20131964. https:\/\/doi.org\/10.1002\/rcm.3048","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1524_CR80","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5935\/0103-507X.20200071","volume":"32","author":"RD Lima","year":"2020","unstructured":"Lima RD, Simon D, Silva WD et al (2020) Prognostic utility of early plasma matrix metalloproteinases-2 and-9 concentrations after severe traumatic brain injury. Rev Bras Ter Intensiva 32:418\u2013425. https:\/\/doi.org\/10.5935\/0103-507X.20200071","journal-title":"Rev Bras Ter Intensiva"},{"issue":"14","key":"1524_CR81","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1089\/neu.2020.7015","volume":"38","author":"S Liraz-Zaltsman","year":"2021","unstructured":"Liraz-Zaltsman S, Friedman-Levi Y, Shabashov-Stone D et al (2021) Chemokine receptors CC chemokine receptor 5 and CXC motif chemokine receptor 4 are new therapeutic targets for brain recovery after traumatic brain injury. J Neurotrauma 38(14):2003\u20132017. https:\/\/doi.org\/10.1089\/neu.2020.7015","journal-title":"J Neurotrauma"},{"key":"1524_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1173-x","volume":"15","author":"YW Liu","year":"2018","unstructured":"Liu YW, Li S, Dai SS (2018) Neutrophils in traumatic brain injury (TBI): friend or foe? J Neuroinflammation 15:1\u20138. https:\/\/doi.org\/10.1186\/s12974-018-1173-x","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1524_CR83","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2(1):86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2.1.86","journal-title":"NeuroRx"},{"issue":"4","key":"1524_CR84","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1186\/s12974-018-1173-x","volume":"113","author":"N Lou","year":"2016","unstructured":"Lou N, Takano T, Pei Y, Xavier AL, Goldman SA, Nedergaard M (2016) Purinergic receptor P2RY12-dependent microglial closure of the injured blood\u2013brain barrier. Proc Natl Acad Sci U S A 113(4):1074\u20131079. https:\/\/doi.org\/10.1186\/s12974-018-1173-x","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1524_CR85","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12974-018-1173-x","volume":"21","author":"BP Lucke-Wold","year":"2018","unstructured":"Lucke-Wold BP, Logsdon AF, Nguyen L et al (2018) Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury. Nutr Neurosci 21(2):79\u201391. https:\/\/doi.org\/10.1186\/s12974-018-1173-x","journal-title":"Nutr Neurosci"},{"key":"1524_CR86","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.redox.2018.03.005","volume":"16","author":"MW Ma","year":"2018","unstructured":"Ma MW, Wang J, Dhandapani KM et al (2018) NADPH oxidases in traumatic brain injury\u2013promising therapeutic targets? Redox Biol 16:285\u2013293. https:\/\/doi.org\/10.1016\/j.redox.2018.03.005","journal-title":"Redox Biol"},{"issue":"4","key":"1524_CR87","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/med.21888","volume":"42","author":"A Mahmood","year":"2022","unstructured":"Mahmood A, Iqbal J (2022) Purinergic receptors modulators: an emerging pharmacological tool for disease management. Med Res Rev 42(4):1661\u20131703. https:\/\/doi.org\/10.1002\/med.21888","journal-title":"Med Res Rev"},{"key":"1524_CR88","doi-asserted-by":"publisher","first-page":"108400","DOI":"10.1016\/j.neuropharm.2020.108400","volume":"183","author":"S Manivannan","year":"2021","unstructured":"Manivannan S, Marei O, Elalfy O et al (2021a) Neurogenesis after traumatic brain injury-The complex role of HMGB1 and neuroinflammation. Neuropharmacology 183:108400. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108400","journal-title":"Neuropharmacology"},{"key":"1524_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-021-01158-3","volume":"21","author":"S Manivannan","year":"2021","unstructured":"Manivannan S, Wales E, Zaben M (2021b) The role of HMGB1 in traumatic brain injury\u2014bridging the gap between the laboratory and clinical studies. Curr Neurol Neurosci Rep 21:1\u20137. https:\/\/doi.org\/10.1007\/s11910-021-01158-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1524_CR90","doi-asserted-by":"publisher","DOI":"10.17226\/25394","author":"C Matney","year":"2022","unstructured":"Matney C, Bowman K, Berwick D, Academies N, of Sciences, Engineering, and Medicine, (2022) The scope and burden of traumatic brain injury in traumatic brain injury: a roadmap for accelerating progress. Nat Acad Press (US). https:\/\/doi.org\/10.17226\/25394","journal-title":"Nat Acad Press (US)"},{"issue":"13","key":"1524_CR91","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1089\/neu.2018.6027","volume":"36","author":"K Mendoza","year":"2019","unstructured":"Mendoza K, Derry PJ, Cherian LM et al (2019) Functional and structural improvement with a catalytic carbon nano-antioxidant in experimental traumatic brain injury complicated by hypotension and resuscitation. J Neurotrauma 36(13):2139\u20132146. https:\/\/doi.org\/10.1089\/neu.2018.6027","journal-title":"J Neurotrauma"},{"issue":"12","key":"1524_CR92","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.3390\/ijms22126418","volume":"22","author":"S Michinaga","year":"2021","unstructured":"Michinaga S, Koyama Y (2021) Pathophysiological responses and roles of astrocytes in traumatic brain injury. Int J Mol Sci 22(12):6418. https:\/\/doi.org\/10.3390\/ijms22126418","journal-title":"Int J Mol Sci"},{"key":"1524_CR93","doi-asserted-by":"publisher","first-page":"112957","DOI":"10.1016\/j.expneurol.2019.112957","volume":"320","author":"IW Nasr","year":"2019","unstructured":"Nasr IW, Chun Y, Kannan S (2019) Neuroimmune responses in the developing brain following traumatic brain injury. Exp Neurol 320:112957. https:\/\/doi.org\/10.1016\/j.expneurol.2019.112957","journal-title":"Exp Neurol"},{"key":"1524_CR94","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.dscb.2022.100038","volume":"6","author":"J Nath","year":"2022","unstructured":"Nath J, Roy R, Sathyamoorthy YK et al (2022) Resveratrol as a therapeutic choice for traumatic brain injury: an insight into its molecular mechanism of action. Brain Disorders. 6:100038","journal-title":"Brain Disorders."},{"key":"1524_CR95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2019.04.005","volume":"332","author":"EJ Needham","year":"2019","unstructured":"Needham EJ, Helmy A, Zanier ER et al (2019) The immunological response to traumatic brain injury. J Neuroimmunol 332:112\u2013125. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.04.005","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1524_CR96","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/pharmaceutics13101542","volume":"13","author":"F Neumaier","year":"2021","unstructured":"Neumaier F, Zlatopolskiy BD, Neumaier B (2021) Drug penetration into the central nervous system: pharmacokinetic concepts and in vitro model systems. Pharmaceutics 13(10):1542. https:\/\/doi.org\/10.3390\/pharmaceutics13101542","journal-title":"Pharmaceutics"},{"key":"1524_CR97","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","volume":"13","author":"SY Ng","year":"2019","unstructured":"Ng SY, Lee AY (2019) Traumatic brain injuries: pathophysiology and potential therapeutic targets. Front Cell Neurosci 13:528. https:\/\/doi.org\/10.3389\/fncel.2019.00528","journal-title":"Front Cell Neurosci"},{"key":"1524_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01778-5","volume":"17","author":"WT O\u2019Brien","year":"2020","unstructured":"O\u2019Brien WT, Pham L, Symons GF et al (2020) The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target. J Neuroinflammation 17:1\u20132. https:\/\/doi.org\/10.1186\/s12974-020-01778-5","journal-title":"J Neuroinflammation"},{"issue":"5","key":"1524_CR99","doi-asserted-by":"publisher","first-page":"542","DOI":"10.23736\/S0390-5616.18.04501-0","volume":"62","author":"O\u2019leary RA, Nichol AD,","year":"2018","unstructured":"O\u2019leary RA, Nichol AD, (2018) Pathophysiology of severe traumatic brain injury. J Neurosurg Sci 62(5):542\u2013548. https:\/\/doi.org\/10.23736\/S0390-5616.18.04501-0","journal-title":"J Neurosurg Sci"},{"key":"1524_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40279-017-0847-3","volume":"48","author":"JM Oliver","year":"2018","unstructured":"Oliver JM, Anzalone AJ, Turner SM (2018) Protection before impact: the potential neuroprotective role of nutritional supplementation in sports-related head trauma. Sports Med 48:39\u201352. https:\/\/doi.org\/10.1007\/s40279-017-0847-3","journal-title":"Sports Med"},{"issue":"5","key":"1524_CR101","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/ijms19051539","volume":"19","author":"N Osier","year":"2018","unstructured":"Osier N, McGreevy E, Pham L et al (2018) Melatonin as a therapy for traumatic brain injury: a review of published evidence. Int J Mol Sci 19(5):1539. https:\/\/doi.org\/10.3390\/ijms19051539","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1524_CR102","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/ijms21020387","volume":"21","author":"I Ozen","year":"2020","unstructured":"Ozen I, Ruscher K, Nilsson R et al (2020) Interleukin-1 beta neutralization attenuates traumatic brain injury-induced microglia activation and neuronal changes in the globus pallidus. Int J Mol Sci 21(2):387. https:\/\/doi.org\/10.3390\/ijms21020387","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1524_CR103","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3390\/biom10060901","volume":"10","author":"MA Panaro","year":"2020","unstructured":"Panaro MA, Benameur T, Porro C (2020) Extracellular vesicles miRNA cargo for microglia polarization in traumatic brain injury. Biomolecules 10(6):901. https:\/\/doi.org\/10.3390\/biom10060901","journal-title":"Biomolecules"},{"issue":"1","key":"1524_CR104","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s12325-020-01542-4","volume":"38","author":"A Papi","year":"2021","unstructured":"Papi A, Di Stefano AFD, Radicioni M (2021) Pharmacokinetics and safety of single and multiple doses of oral N-acetylcysteine in healthy chinese and caucasian volunteers: an open-label. Phase I Clinical Study Adv Ther 38(1):468\u2013478. https:\/\/doi.org\/10.1007\/s12325-020-01542-4","journal-title":"Phase I Clinical Study Adv Ther"},{"issue":"2","key":"1524_CR105","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrd725","volume":"1","author":"WM Pardridge","year":"2002","unstructured":"Pardridge WM (2002) Drug and gene targeting to the brain with molecular trojan horses. Nat Rev Drug Discov 1(2):131\u2013139. https:\/\/doi.org\/10.1038\/nrd725","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1524_CR106","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/02699052.2016.1217045","volume":"31","author":"TM Parker","year":"2017","unstructured":"Parker TM, Nguyen AH, Rabang JR et al (2017) The danger zone: systematic review of the role of HMGB1 danger signalling in traumatic brain injury. Brain Inj 31(1):2\u20138. https:\/\/doi.org\/10.1080\/02699052.2016.1217045","journal-title":"Brain Inj"},{"key":"1524_CR107","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00011-018-1154-7","volume":"67","author":"DA Patten","year":"2018","unstructured":"Patten DA (2018) SCARF1: a multifaceted, yet largely understudied, scavenger receptor. Inflamm Res 67:627\u2013632. https:\/\/doi.org\/10.1007\/s00011-018-1154-7","journal-title":"Inflamm Res"},{"issue":"1","key":"1524_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1383-2","volume":"16","author":"ST Peruzzaro","year":"2019","unstructured":"Peruzzaro ST, Andrews MM, Al-Gharaibeh A et al (2019) Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury. J Neuroinflammation 16(1):1\u20135. https:\/\/doi.org\/10.1186\/s12974-018-1383-2","journal-title":"J Neuroinflammation"},{"key":"1524_CR109","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3389\/fneur.2018.01113","volume":"9","author":"S Polinder","year":"2018","unstructured":"Polinder S, Cnossen MC, Real RG et al (2018) A multidimensional approach to post-concussion symptoms in mild traumatic brain injury. Front Neurol 9:1113. https:\/\/doi.org\/10.3389\/fneur.2018.01113","journal-title":"Front Neurol"},{"issue":"1","key":"1524_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-191150","volume":"74","author":"TT Postolache","year":"2020","unstructured":"Postolache TT, Wadhawan A, Can A et al (2020) (2020) Inflammation in traumatic brain injury. J Alzheimer\u2019s Dis 74(1):1\u201328. https:\/\/doi.org\/10.3233\/JAD-191150","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"10","key":"1524_CR111","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.4049\/jimmunol.1700373","volume":"198","author":"MR PrabhuDas","year":"2017","unstructured":"PrabhuDas MR, Baldwin CL, Bollyky PL et al (2017) A consensus definitive classification of scavenger receptors and their roles in health and disease. J Immunol 198(10):3775\u20133789. https:\/\/doi.org\/10.4049\/jimmunol.1700373","journal-title":"J Immunol"},{"key":"1524_CR112","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.fsi.2019.12.086","volume":"98","author":"X Qiao","year":"2020","unstructured":"Qiao X, Li P, He J et al (2020) Type F scavenger receptor expressed by endothelial cells (SREC)-II from epinephelus coioides is a potential pathogen recognition receptor in the immune response to vibrio parahaemolyticus infection. Fish Shellfish Immunol 98:262\u2013270. https:\/\/doi.org\/10.1016\/j.fsi.2019.12.086","journal-title":"Fish Shellfish Immunol"},{"issue":"6","key":"1524_CR113","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.3390\/ijms160611903","volume":"16","author":"C Reis","year":"2015","unstructured":"Reis C, Wang Y, Akyol O et al (2015) What\u2019s new in traumatic brain injury: update on tracking, monitoring and treatment. Int J Mol Sci 16(6):11903\u201311965. https:\/\/doi.org\/10.3390\/ijms160611903","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1524_CR114","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-019-0168-x","volume":"19","author":"ES Reis","year":"2019","unstructured":"Reis ES, Mastellos DC, Hajishengallis G et al (2019) New insights into the immune functions of complement. Nat Rev Immunol 19(8):503\u2013516. https:\/\/doi.org\/10.1038\/s41577-019-0168-x","journal-title":"Nat Rev Immunol"},{"key":"1524_CR115","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neulet.2016.02.025","volume":"617","author":"MC Rich","year":"2016","unstructured":"Rich MC, Keene CN, Neher MD et al (2016) Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains. Neurosci Lett 617:188\u2013194. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.025","journal-title":"Neurosci Lett"},{"issue":"13","key":"1524_CR116","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1089\/neu.2017.5399","volume":"35","author":"RM Ritzel","year":"2018","unstructured":"Ritzel RM, Doran SJ, Barrett JP et al (2018) Chronic alterations in systemic immune function after traumatic brain injury. J Neurotrauma 35(13):1419\u20131436. https:\/\/doi.org\/10.1089\/neu.2017.5399","journal-title":"J Neurotrauma"},{"key":"1524_CR117","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(04)17188-2","volume":"364","author":"I Roberts","year":"2004","unstructured":"Roberts I, Yates D, Sandercock P et al (2004) Effect of intravenous corticosteroids on death within 14\u00a0days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo controlled trial. Lancet 364:1321\u20131328. https:\/\/doi.org\/10.1016\/S0140-6736(04)17188-2","journal-title":"Lancet"},{"key":"1524_CR118","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cyto.2018.01.012","volume":"110","author":"T Rodney","year":"2018","unstructured":"Rodney T, Osier N, Gill J (2018) Pro-and anti-inflammatory biomarkers and traumatic brain injury outcomes: a review. Cytokine 110:248\u2013256. https:\/\/doi.org\/10.1016\/j.cyto.2018.01.012","journal-title":"Cytokine"},{"key":"1524_CR119","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fneur.2019.00458","volume":"10","author":"Z Rossini","year":"2019","unstructured":"Rossini Z, Nicolosi F, Kolias AG et al (2019) The history of decompressive craniectomy in traumatic brain injury. Front Neurol 10:458. https:\/\/doi.org\/10.3389\/fneur.2019.00458","journal-title":"Front Neurol"},{"issue":"1","key":"1524_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1200-y","volume":"15","author":"RK Rowe","year":"2018","unstructured":"Rowe RK, Harrison JL, Zhang H et al (2018) Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury. J Neuroinflammation 15(1):1\u20134. https:\/\/doi.org\/10.1186\/s12974-018-1200-y","journal-title":"J Neuroinflammation"},{"key":"1524_CR121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.wneu.2020.04.185","volume":"140","author":"E Sabouri","year":"2020","unstructured":"Sabouri E, Majdi A, Jangjui P et al (2020) Neutrophil-to-lymphocyte ratio and traumatic brain injury: a review study. World Neurosurg 140:142\u2013147. https:\/\/doi.org\/10.1016\/j.wneu.2020.04.185","journal-title":"World Neurosurg"},{"key":"1524_CR122","doi-asserted-by":"publisher","first-page":"134347","DOI":"10.1016\/j.neulet.2019.134347","volume":"710","author":"DK Sahel","year":"2019","unstructured":"Sahel DK, Kaira M, Raj K et al (2019) Mitochondrial dysfunctioning and neuroinflammation: recent highlights on the possible mechanisms involved in traumatic brain injury. Neurosci Lett 710:134347. https:\/\/doi.org\/10.1016\/j.neulet.2019.134347","journal-title":"Neurosci Lett"},{"issue":"1","key":"1524_CR123","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/pharmaceutics13010095","volume":"13","author":"MAA Saleh","year":"2021","unstructured":"Saleh MAA, de Lange ECM (2021) Impact of CNS diseases on drug delivery to brain extracellular and intracellular target sites in human: a \u201cWHAT-IF\u201d simulation study. Pharmaceutics 13(1):95. https:\/\/doi.org\/10.3390\/pharmaceutics13010095","journal-title":"Pharmaceutics"},{"issue":"3","key":"1524_CR124","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/medicina56030137","volume":"56","author":"G Schepici","year":"2020","unstructured":"Schepici G, Silvestro S, Bramanti P et al (2020) Traumatic brain injury and stem cells: an overview of clinical trials, the current treatments and future therapeutic approaches. Medicina 56(3):137. https:\/\/doi.org\/10.3390\/medicina56030137","journal-title":"Medicina"},{"key":"1524_CR125","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11055-022-01337-w","volume":"52","author":"NB Serebryanaya","year":"2022","unstructured":"Serebryanaya NB, Fomicheva EE, Yakutseni PP (2022) Purinergic regulation of neuroinflammation in traumatic brain injury. Neurosci Behav Physiol 52:1093\u20131106","journal-title":"Neurosci Behav Physiol"},{"key":"1524_CR126","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuropharm.2018.07.022","volume":"145","author":"H Shi","year":"2019","unstructured":"Shi H, Hua X, Kong D et al (2019) Role of Toll-like receptor mediated signaling in traumatic brain injury. Neuropharmacology 145:259\u2013267. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.022","journal-title":"Neuropharmacology"},{"issue":"10","key":"1524_CR127","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/cpdd.925","volume":"10","author":"H Shimizu","year":"2021","unstructured":"Shimizu H, Nishimura Y, Shiide Y et al (2021) Evaluation of pharmacokinetics, safety, and drug-drug interactions of an oral suspension of edaravone in healthy adults. Clin Pharmacol Drug Dev 10(10):1174\u20131187. https:\/\/doi.org\/10.1002\/cpdd.925","journal-title":"Clin Pharmacol Drug Dev"},{"key":"1524_CR128","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jflm.2018.02.016","volume":"55","author":"M Sieber","year":"2018","unstructured":"Sieber M, Dre\u00dfler J, Franke H et al (2018) Post-mortem biochemistry of NSE and S100B: a supplemental tool for detecting a lethal traumatic brain injury? J Forensic Leg Med 55:65\u201373. https:\/\/doi.org\/10.1016\/j.jflm.2018.02.016","journal-title":"J Forensic Leg Med"},{"key":"1524_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroscience.2017.12.021","volume":"376","author":"S Singh","year":"2018","unstructured":"Singh S, Houng AK, Reed GL (2018) Matrix metalloproteinase-9 mediates the deleterious effects of \u03b12-antiplasmin on blood\u2013brain barrier breakdown and ischemic brain injury in experimental stroke. Neuroscience 376:40\u201347. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.12.021","journal-title":"Neuroscience"},{"key":"1524_CR130","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s10072-019-04238-y","volume":"41","author":"D Slavoaca","year":"2020","unstructured":"Slavoaca D, Muresanu D, Birle C et al (2020) Biomarkers in traumatic brain injury: new concepts. Neurol Sci 41:2033\u20132044. https:\/\/doi.org\/10.1007\/s10072-019-04238-y","journal-title":"Neurol Sci"},{"issue":"12","key":"1524_CR131","doi-asserted-by":"publisher","first-page":"e0167677","DOI":"10.1371\/journal.pone.0167677","volume":"11","author":"J Szmydynger-Chodobska","year":"2016","unstructured":"Szmydynger-Chodobska J, Shan R, Thomasian N, Chodobski A (2016) The involvement of pial microvessels in leukocyte invasion after mild traumatic brain injury. PLoS ONE 11(12):e0167677. https:\/\/doi.org\/10.1371\/journal.pone.0167677","journal-title":"PLoS ONE"},{"issue":"9","key":"1524_CR132","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","volume":"71","author":"K Thapa","year":"2021","unstructured":"Thapa K, Khan H, Singh TG, Kaur A (2021) Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets. J Mol Neurosci 71(9):1725\u20131742. https:\/\/doi.org\/10.1007\/s12031-021-01841-7","journal-title":"J Mol Neurosci"},{"issue":"22","key":"1524_CR133","doi-asserted-by":"publisher","first-page":"eaax8847","DOI":"10.1126\/sciadv.aax8847","volume":"6","author":"K Vaibhav","year":"2020","unstructured":"Vaibhav K, Braun M, Alverson K et al (2020) Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury. Sci Adv 6(22):eaax8847. https:\/\/doi.org\/10.1126\/sciadv.aax8847","journal-title":"Sci Adv"},{"issue":"20","key":"1524_CR134","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.3390\/ijms21207586","volume":"21","author":"L Veenman","year":"2020","unstructured":"Veenman L (2020) Raloxifene as treatment for various types of brain injuries and neurodegenerative diseases: a good start. Int J Mol Sci 21(20):7586. https:\/\/doi.org\/10.3390\/ijms21207586","journal-title":"Int J Mol Sci"},{"key":"1524_CR135","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3389\/fimmu.2018.01330","volume":"9","author":"Vourc\u2019h M, Roquilly A, Asehnoune K,","year":"2018","unstructured":"Vourc\u2019h M, Roquilly A, Asehnoune K, (2018) Trauma-induced damage-associated molecular patterns-mediated remote organ injury and immunosuppression in the acutely ill patient. Front Immun 9:1330. https:\/\/doi.org\/10.3389\/fimmu.2018.01330","journal-title":"Front Immun"},{"issue":"2","key":"1524_CR136","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1172\/JCI76210","volume":"125","author":"JT Walsh","year":"2015","unstructured":"Walsh JT, Hendrix S, Boato F et al (2015) MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J Clin Invest 125(2):699\u2013714. https:\/\/doi.org\/10.1172\/JCI76210","journal-title":"J Clin Invest"},{"key":"1524_CR137","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s11064-015-1634-x","volume":"40","author":"XY Wang","year":"2015","unstructured":"Wang XY, Ba YC, Xiong LL et al (2015) Endogenous TGF\u03b21 plays a crucial role in functional recovery after traumatic brain injury associated with Smad3 signal in rats. Neurochem Res 40:1671\u20131680. https:\/\/doi.org\/10.1007\/s11064-015-1634-x","journal-title":"Neurochem Res"},{"key":"1524_CR139","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","volume":"35","author":"F Weisel","year":"2017","unstructured":"Weisel F, Shlomchik M (2017) Memory B cells of mice and humans. Ann Rev Immunol 35:255\u2013284. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055531","journal-title":"Ann Rev Immunol"},{"key":"1524_CR140","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejps.2013.12.020","volume":"57","author":"J Westerhout","year":"2014","unstructured":"Westerhout J, van den Berg DJ, Hartman R et al (2014) Prediction of methotrexate CNS distribution in different species - influence of disease conditions. Eur J Pharm Sci 57:11\u201324. https:\/\/doi.org\/10.1016\/j.ejps.2013.12.020","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"1524_CR141","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/cpt1975184377","volume":"18","author":"GR Wilkinson","year":"1975","unstructured":"Wilkinson GR, Shand DG (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18(4):377\u2013390. https:\/\/doi.org\/10.1002\/cpt1975184377","journal-title":"Clin Pharmacol Ther"},{"key":"1524_CR142","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbi.2018.11.012","volume":"76","author":"R Wong","year":"2019","unstructured":"Wong R, L\u00e9n\u00e1rt N, Hill L et al (2019) Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons. Brain Behav Immun 76:126\u2013138. https:\/\/doi.org\/10.1016\/j.bbi.2018.11.012","journal-title":"Brain Behav Immun"},{"key":"1524_CR143","doi-asserted-by":"publisher","first-page":"146553","DOI":"10.1016\/j.brainres.2019.146553","volume":"1727","author":"MY Wu","year":"2020","unstructured":"Wu MY, Gao F, Yang XM et al (2020) Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury. Brain Res 1727:146553. https:\/\/doi.org\/10.1016\/j.brainres.2019.146553","journal-title":"Brain Res"},{"issue":"4","key":"1524_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11173","volume":"23","author":"LL Xie","year":"2022","unstructured":"Xie LL, Li SS, Fan YJ et al (2022) Melatonin alleviates traumatic brain injury-induced anxiety-like behaviors in rats: Roles of the protein kinase A\/cAMP-response element binding signaling pathway. Exp Therap Med 23(4):1\u20132. https:\/\/doi.org\/10.3892\/etm.2022.11173","journal-title":"Exp Therap Med"},{"issue":"03","key":"1524_CR145","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cjtee.2018.02.003","volume":"21","author":"Y Xiong","year":"2018","unstructured":"Xiong Y, Mahmood A, Chopp M (2018) Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities. Chin J Traumatol 21(03):137\u2013151. https:\/\/doi.org\/10.1016\/j.cjtee.2018.02.003","journal-title":"Chin J Traumatol"},{"issue":"8","key":"1524_CR146","doi-asserted-by":"publisher","first-page":"e13092","DOI":"10.1111\/cpr.13092","volume":"54","author":"L Xu","year":"2021","unstructured":"Xu L, Ye X, Wang Q et al (2021) T-cell infiltration, contribution and regulation in the central nervous system post-traumatic injury. Cell Prolif 54(8):e13092. https:\/\/doi.org\/10.1111\/cpr.13092","journal-title":"Cell Prolif"},{"issue":"6","key":"1524_CR147","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1159\/000489659","volume":"46","author":"L Yang","year":"2018","unstructured":"Yang L, Wang F, Yang L et al (2018a) HMGB1 a-box reverses brain edema and deterioration of neurological function in a traumatic brain injury mouse model. Cell Physiol Biochem 46(6):2532\u20132542. https:\/\/doi.org\/10.1159\/000489659","journal-title":"Cell Physiol Biochem"},{"issue":"53","key":"1524_CR148","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/pm.pm_218_17","volume":"14","author":"Z Yang","year":"2018","unstructured":"Yang Z, Fan R, Sun P et al (2018b) Rhubarb attenuates cerebral edema via inhibition of the extracellular signal-regulated kinase pathway following traumatic brain injury in rats. Pharmacogn Mag 14(53):134. https:\/\/doi.org\/10.4103\/pm.pm_218_17","journal-title":"Pharmacogn Mag"},{"key":"1524_CR149","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1007\/s12035-018-1428-7","volume":"56","author":"D Younger","year":"2019","unstructured":"Younger D, Murugan M, Rama Rao KV (2019) Microglia receptors in animal models of traumatic brain injury. Mol Neurobiol 56:5202\u20135228. https:\/\/doi.org\/10.1007\/s12035-018-1428-7","journal-title":"Mol Neurobiol"},{"key":"1524_CR150","doi-asserted-by":"publisher","first-page":"153601212092760","DOI":"10.1177\/1536012120927609","volume":"19","author":"H Zarrinmayeh","year":"2020","unstructured":"Zarrinmayeh H, Territo PR (2020) Purinergic receptors of the central nervous system: biology, PET ligands, and their applications. Mol Imaging 19:1536012120927609. https:\/\/doi.org\/10.1177\/1536012120927609","journal-title":"Mol Imaging"},{"issue":"1","key":"1524_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-00549-2","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Shao A, Yao Y et al (2020) Dual roles of astrocytes in plasticity and reconstruction after traumatic brain injury. Cell Commun Signal 18(1):1\u20136. https:\/\/doi.org\/10.1186\/s12964-020-00549-2","journal-title":"Cell Commun Signal"},{"key":"1524_CR152","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","volume":"15","author":"J Zindel","year":"2020","unstructured":"Zindel J, Kubes P (2020) DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu Rev Pathol: Mechanisms of Disease 15:493\u2013518. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012419-032847","journal-title":"Annu Rev Pathol: Mechanisms of Disease"},{"key":"1524_CR153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fimmu.2016.00075","volume":"7","author":"D Zuo","year":"2016","unstructured":"Zuo D, Subjeck J, Wang XY (2016) Unfolding the role of large heat shock proteins: new insights and therapeutic implications. Front Immunol 7:75. https:\/\/doi.org\/10.3389\/fimmu.2016.00075","journal-title":"Front Immunol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01524-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T16:07:14Z","timestamp":1726934834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01524-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}